Fifty years ago, on November 29, 1975, the Individuals with Disabilities Education Act (IDEA) was signed into law. This law ensures the rights of individuals with special needs and disabilities to receive a free appropriate public education (FAPE), including our loved ones with Prader-Willi syndrome. Without this law, many, perhaps most, of our loved ones...
Category: Advocacy
Calling Indiana PWS Families!
The Indiana Medicaid Drug Utilization Review (DUR) Board Meeting will be meeting October 17, 2025, starting at 10:00 AM EST. Here’s how you can help: The Indiana Medicaid DUR Board needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS. One...
Calling Missouri PWS Families!
The Missouri Rare Disease Advisory Council Meeting will be meeting October 8, 2025 from 10:30 AM – 2 PM CDT. Here’s how you can help: The Missouri Rare Disease Advisory Council needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS....
Understanding P&T Committees and DUR Boards
Why do P&T Committees and DUR Boards Matter for PWS Treatments? For families living with Prader-Willi syndrome, access to new therapies isn’t just about FDA approval. Once a drug is approved, there’s another critical step that determines whether patients can actually receive treatment: coverage decisions made by Pharmacy & Therapeutics (P&T) Committees and Drug Utilization...
Calling Alaska PWS Families
The Alaska Medical Assistance DUR Committee will be meeting virtually at 1 PM AKDT on Friday, Sept. 19, 2025. Here’s how you can help: The Alaska Drug Utilization Review Board needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS. One...
Calling Montana PWS Families
The Montana Medicaid Drug Use Review Board will be meeting virtually from 1 PM – 5 PM MT on Wednesday, Sept. 17, 2025. Here’s how you can help: The Medicaid Drug Use Review Board needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger)...
Calling Minnesota PWS Families
The Minnesota Drug Formulary Committee Meeting will be open at 9 AM CT on Wednesday, Sept. 17, 2025. Here’s how you can help: The Drug Formulary Committee needs to hear directly from you – the parents, caregivers, and family members who understand the real-life impact of hyperphagia (excessive hunger) in PWS. One of the...
Michigan PWS Families – Your Voices are Needed!
The Michigan Pharmacy and Therapeutics Committee will hold a Drug Utilization Review (DUR) Board meeting on September 2, 2025, at 6 PM. Please submit your comment by August 20, 2025. Here’s how you can help: The DUR Board needs to hear directly from you – the parents, caregivers, and family members who understand the real-life...
PWS Advocates Participate in Rare Across America Congressional Meetings
Rare Across America, sponsored by the EveryLife Foundation for Rare Diseases, is held every August when Congress is on summer recess and our elected officials are in their home districts. It is an opportunity for advocates to meet with their Members of Congress and staff at their in-district offices and educate them on the issues...
Colorado PWS Families – Your Voices are Needed!
The Colorado Department of Health Care Policy & Financing will hold a Drug Utilization Review (DUR) Board meeting on August 12, 2025, from 1:00 to 5:00 p.m. (MT). This important meeting will review medications covered by Health First Colorado (Colorado’s Medicaid program) including those that could change the lives of individuals with Prader-Willi syndrome (PWS)....
Exciting News! PWS Included in FY26 Department of Defense Appropriations Bill for Medical Research
We are thrilled to share that Prader-Willi syndrome has been included in the Department of Defense’s (DOD) Peer-Reviewed Medical Research Program (PRMRP) in the 2026 Fiscal Year Defense Appropriations Bill. This is a MAJOR milestone for our community! This inclusion, passed out of the Senate Appropriations Committee, is the result of tireless advocacy efforts that...
PWSA | USA Helps Usher in New Era of Rare Disease Research with Launch of Florida’s Sunshine Genetics Act
Florida has officially launched the Sunshine Genetics Act, a first-of-its-kind initiative offering free, voluntary whole genome sequencing (WGS) for all newborns—and PWSA | USA was honored to stand at the forefront of this historic moment for rare disease families. On July 9, 2025, leaders in science, medicine, and policy gathered at Florida State University’s Interdisciplinary...
PWSA | USA Advocacy Ambassadors Join Forces with Patients Rising on Capitol Hill
Six of our dedicated PWSA | USA Advocacy Ambassadors (Dorothea Lantz, Elaine Towle, Jessica Kempa, Sheri Mills, Michelle Torbert and Jennifer Garzia—also joined by her family, including her son Rocco who is 20 years old living with PWS) traveled to Washington, D.C. last week to take part in Patients Rising’s 4th annual “We the Patients”...
PWSA Advocates Represent Disability Needs and Rights in DC
submitted by Dorothea Lantz, PWSA | USA’s Director of Community Engagement PWSA | USA Advocacy Community Update – Capitol Hill Recap (May 5–8, 2025) From May 5th–8th, six of our PWSA | USA Advocacy Ambassadors joined forces with the Council of Parent Attorneys and Advocates (COPAA) and key partners from the rare disease industry to...
Take Action: Help Pass the Sunshine Genetics Act in Florida!
Your voice matters! Florida has the opportunity to lead the way in early genetic screening for rare diseases like Prader-Willi syndrome (PWS). By supporting the Sunshine Genetics Act (HB 907 / SB 1356), we can help ensure that newborns receive critical genetic testing, leading to earlier diagnoses and improved care for individuals affected by rare...
United for Change: PWSA | USA Advocates Make a Powerful Impact During Rare Disease Week 2025
Rare Disease Week on Capitol Hill 2025 was a transformative experience for the Prader-Willi syndrome (PWS) community and the broader rare disease advocacy movement. From February 24–26th, 36 advocates from PWSA | USA, including 10 individuals living with PWS and members of the Advocacy Ambassador program, traveled to Washington, D.C., to share their stories, educate...
Reflections from Rare Disease Week Advocates
Part of our PWSA | USA team, along with fellow PWS advocates, attended Rare Disease Week in Washington, DC, February 24-26. Our advocates attended group lectures and sessions alongside other rare disease advocates the first part of the week, then met with their elected officials on Wednesday. Our advocates say they had a successful experience...
Join Rare Disease Week Advocacy from Home
Our advocates are in Washington, D.C. this week for Rare Disease Week (February 28 is Rare Disease Day!). On Wednesday they will be meeting with their representatives to advocate for PWS and the rare disease community. While not everyone can travel to D.C. themselves, you can get in touch with your representative via phone or...
Call to Action: Save Our Clinical Trials
We’ve made it easy to contact your representative about a very important issue affecting the PWS community. Read below to learn about this issue then click the button at the bottom to be taken to a pre-written letter. Fill in your name, street address, zip code, phone, email and hit send. The Biggest Threat to...
Victory for the PWS Community in Illinois
We are thrilled to celebrate a major step forward for individuals living with Prader-Willi syndrome (PWS) and the broader rare disease community in Illinois! On February 4, 2025, SB1651, filed by Senator Morrison, and HB2541, filed by Representative La Ha, were introduced—marking a critical move toward better support and services for those affected by PWS. ...
Advocates Secure Policy Progress for PWS Community at Texas Governor’s Committee on People with Disabilities Meeting
On Friday, January 24, 2025, the Texas Prader-Willi syndrome (PWS) community achieved a significant milestone during the Texas Governor’s Committee on People with Disabilities meeting. Our dedicated advocates Tim Joniec and June Finnerty testified on behalf of individuals living with PWS in Texas, shedding light on critical unmet needs and proposing policy changes to better...
Changes at FDA’s Center for Drug Evaluation and Research
The Prader-Willi Syndrome Association | USA (PWSA | USA) and the Foundation for Prader-Willi Research (FPWR) would like to take a moment to acknowledge a significant leadership transition at the U.S. Food and Drug Administration (FDA). As Dr. Patrizia Cavazzoni steps down as Director of the Center for Drug Evaluation and Research (CDER), we express...
PWS Advocacy Master Class: Register Before January 13th!
Launching on January 13, 2025, the PWS Advocacy Master Class is a six-week program designed in collaboration with Patients Rising. It provides a robust curriculum for anyone passionate about becoming an effective advocate for PWS. Course Highlights: – Congress 101: A deep dive into how laws are made and how to engage with policymakers. – Pharmacy...
Advocating for Rare Diseases: Year-End Highlights and Uncertain Next Steps
Dorothea Lantz, PWSA | USA Community Engagement Director, and Elaine Towle, PWSA | USA volunteer advocate, recently represented the rare disease community in critical meetings on Capitol Hill with Sen. Shaheen, Sen. Hassan, Sen. Rubio, and Sen. Braun. These discussions emphasized advancing legislative priorities for 2025, including rare disease drug development, improving Medicaid access for...